More than one million North Carolinian patients are affected by a rare disease. Tara Britt, our founder, argues that removing IP protections from medical innovation will lead to less cures and treatments for rare diseases. Keep reading in @dailyreflector: https://www.reflector.com/opinion/editorial_columnists/well-intended-measure-will-throttle-pharma-innovation/article_44f6722a-5cce-5c64-8c28-b19992f32b0d.html
Well-intended measure will throttle pharma innovation
